Esculetin Loaded Chitosan Nanoparticles (ESC-CNPs) Ameliorates 7, 12 Dimethylbenz [a] Anthracene (DMBA) Induced Breast Cancer in Rat Model
Siva Sankari Thirugnanam1, Subashini Ragunathan2★, Monisha Prasad3★ Corresponding author
- 1Deparment of Biochemistry and Biotechnology, Annamalai University, Chidambaram, Tamil Nadu, INDIA.
- 2Deparment of Biochemistry and Biotechnology, D. G. Government Arts College for Women, Annamalai University, Mayiladuthurai, Tamil Nadu, INDIA.
- 3Centre for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, INDIA.
CORRESPONDENCE
Subashini Ragunathan
Dr. R. Subashini, M.Sc., M.Phil., Ph. D, FSAB, Assistant Professor, Department of Biochemistry, D. G. Government Arts College for Women (Annamalai University), Mayiladuthurai-609001, Tamil Nadu, INDIA.
Received: 28-10-2024; Revised: 28-11-11; Accepted: 03-12-2024.
Volume 17, Issue 1 · pp. 207–220 · PUBLISHED 2025 · DOI: 10.5530/pres.20251996
View on Pharmacogn. Res. original site ↗
ABSTRACT
Aim This study aimed to explore the chemopreventive potential of Esculetin-loaded Chitosan Nanoparticles (ESC-CNPs) against mammary carcinogenesis induced by 7,12-Dimethylbenz[a]Anthracene (DMBA) in female Sprague-Dawley rats. Materials and Methods DMBA, administered subcutaneously at a dose of 25 mg/rat near the mammary gland, triggered the formation of breast tumors. Female Sprague-Dawley rats were induced with mammary tumors via a single subcutaneous injection of DMBA. The treatment groups received ESC-CNPs orally at dosages of 25, 50 and 100 mg/kg body weight (bw). Biochemical parameters, including lipid peroxidation (TBARS and LOOH), antioxidant status (SOD, CAT, GPX and GSH), phase I (CYP450, Cyt-b5) and phase II (GST, GR) enzymes and lipid profiles (TC, TG, PL, FFA), were evaluated in plasma and breast tissues. Additionally, the expression of VEGF, NF-kB and Cyclin D1 was analyzed through histopathology and western blotting. Results DMBA-induced rats exhibited decreased body weight, increased tumor volume and incidence, elevated lipid peroxidation, reduced antioxidant status, altered liver and mammary tissue enzyme levels and disrupted lipid profiles. ESC-CNPs treatment, particularly at 100 mg/kg bw, significantly reduced tumor occurrence, normalized biochemical markers and downregulated VEGF, NF-kB and Cyclin D1 expression in mammary tissues. Conclusion ESC-CNPs, at a dose of 100 mg/kg bw, demonstrated a potent chemopreventive effect against DMBA-induced mammary cancer, as evidenced by biochemical, histopathological and molecular findings.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Thirugnanam, S. S., Ragunathan, S., & Prasad, M. (2025). Esculetin Loaded Chitosan Nanoparticles (ESC-CNPs) Ameliorates 7, 12 Dimethylbenz [a] Anthracene (DMBA) Induced Breast Cancer in Rat Model. Pharmacognosy Research, 17(1), 207–220. https://doi.org/10.5530/pres.20251996
